PSIL

AdvisorShares Psychedelics ETFAdvisorShares
$16.86-0.17 (-1.03%)Live
AUM$20.4M
Expense Ratio1.84%
NAV$17.23
Holdings25
InceptionSep 15, 2021

Price Chart

Key Statistics

Previous Close

$17.03

Day Range

$16.80$17.29

52-Week Range

$9.94$21.59

Avg Volume

13.9K

Dividend Yield

10.70%

Expense Ratio

1.84%

AUM

$20.4M

Shares Outstanding

1.2M

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States52.25%
Ireland12.98%
Canada12.45%
Netherlands10.54%
United Kingdom10.27%
Australia1.01%
Other0.50%

Fund Information

Category
Healthcare
Inception Date
Sep 15, 2021
Exchange
NYSE_ARCA
Description
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Similar ETFs

SymbolNameAUMExpense RatioHoldings
IWMiShares Russell 2000 ETF$70.17B0.19%1,934
XLVState Street Health Care Select Sector SPDR ETF$40.61B0.08%60
VHTVanguard Health Care ETF$19.80B0.09%411
COWZPacer US Cash Cows 100 ETF$18.40B0.49%103
VTWOVanguard Russell 2000 ETF$14.50B0.06%1,969

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund issued by AdvisorShares that launched on Sep 15, 2021. It currently manages $20.4M in assets under management. The fund charges an expense ratio of 1.84%. The fund holds 25 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 71.1% of the fund

RankSymbolNameWeight %SharesMarket Value
1ATAIATAIBECKLEY INC10.49%567,587$2.2M
2CMPSCOMPASS PATHWAYS PLC10.22%255,739$2.1M
3DFTXDefinium Therapeutics, Inc9.10%108,901$1.9M
4RLMDRELMADA THERAPEUTICS INC7.15%338,872$1.5M
5ALKSALKERMES PLC6.86%44,269$1.4M
6GHRSGH RESEARCH PLC6.07%79,334$1.3M
7NBIXNEUROCRINE BIOSCIENCES INC5.58%8,870$1.2M
8HELPCYBIN INC5.40%161,604$1.1M
9ANROALTO NEUROSCIENCE INC5.36%56,823$1.1M
10DRUGBRIGHT MINDS BIOSCIENCES INC4.92%11,813$1.0M
11SUPNSUPERNUS PHARMACEUTICALS INC4.83%19,453$999K
12ABBVABBVIE INC4.09%3,765$845K
13JNJJOHNSON & JOHNSON4.04%3,378$834K
14NRXPNRX PHARMACEUTICALS INC3.30%370,467$682K
15NEUPNEUPHORIA THERAPEUTICS INC3.08%148,627$638K

Detailed Returns

PeriodReturnETFCat. Avgvs Avg
1D
-1.03%
1W
+3.39%
1M
+2.16%
3M
-11.30%
6M
-3.57%
YTD
-0.99%
1Y
+41.86%
3Y
-6.94%
5Y
-82.94%

Moving Averages

20-Day MA

$17.02

Below 20-Day MA
50-Day MA

$17.15

Below 50-Day MA
200-Day MA

$17.10

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$21.59

Current Price

$16.86

52-Week Low

$9.94

$9.94$21.59

Current Yield

10.70%

Annual Dividend

$1.8793

Frequency

4x/year

Last Ex-Date

Dec 22, 2025

Dividend History

Ex-DateAmountPay Date
Dec 22, 2025$1.6839Dec 29, 2025
Sep 22, 2025$0.0201Sep 29, 2025
Jun 23, 2025$0.0119Jun 27, 2025
Mar 21, 2025$0.1634Mar 28, 2025
Dec 23, 2024$0.0548Dec 30, 2024
Sep 23, 2024$0.1087Sep 30, 2024
Sep 25, 2023$0.0034Sep 29, 2023
Sep 26, 2022$0.0542Sep 30, 2022

Dividend Payments Over Time

Category Comparison

MetricPSILHealthcare(223 ETFs)Healthcare(29 ETFs)
Fund Info
Expense Ratio1.84%0.60%0.56%
AUM$20.4M$1.25B$531.9M
Dividend Yield10.70%2.75%2.19%
Avg Volume13.9K800.6K114.0K
Holdings25182117
Performance
1-Month Return+2.34%-4.49%-3.37%
6-Month Return-4.82%+4.92%+5.71%
YTD Return-0.82%-1.66%-2.38%
1-Year Return+42.03%+15.04%+15.63%

Compare with Another ETF

Search for an ETF to compare with PSIL: